The Study
Effect of More Intensive LDL-C-Lowering Therapy on Long-term Cardiovascular Outcomes in Early-Phase Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
This study combines results from several well-designed experiments where patients were randomly assigned to different treatments. It shows that lowering cholesterol more aggressively early after a heart attack probably helps prevent future heart problems, especially if cholesterol was high to begin with.
Analysis score
Maximum 100 for a systematic review with meta-analysis.
Where the score came from
When people with a recent heart problem take stronger cholesterol-lowering medicine early, they have fewer heart attacks and strokes later.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 548 / 100
Quality score
The highest quality evidence. These studies systematically search, appraise, and synthesize results from multiple individual studies, providing the most reliable summary of current knowledge.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes, this is meaningful — lowering cholesterol more early after a heart event can prevent future heart attacks and strokes, especially for those starting with high levels.
- 2Stronger treatment lowered bad cholesterol and cut heart problems by 17%.
- 3If cholesterol was very high to start (over 130 mg/dL), the drop in heart problems was 26%.
- 4The more cholesterol went down, the better the results, especially if it dropped over 50%.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Clinical therapeutics
Year
2021
Authors
Siyao Jin, X. Nie, Yuxi Li, Jinjie Yuan, Yi-min Cui, Libo Zhao
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.